Gaining Ground: Heron Therapeutics Inc (HRTX) Closes Higher at 2.87, Up 1.06

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

The price of Heron Therapeutics Inc (NASDAQ: HRTX) closed at $2.87 in the last session, up 1.06% from day before closing price of $2.84. In other words, the price has increased by $1.06 from its previous closing price. On the day, 7.05 million shares were traded. HRTX stock price reached its highest trading level at $3.09 during the session, while it also had its lowest trading level at $2.61.


We take a closer look at HRTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.84 and its Current Ratio is at 2.37.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, CapitalOne on April 23, 2024, initiated with a Overweight rating and assigned the stock a target price of $6.

On March 13, 2024, Needham reiterated its Buy rating and also lowered its target price recommendation from $4 to $5.

On May 27, 2020, Guggenheim started tracking the stock assigning a Buy rating and target price of $24.Guggenheim initiated its Buy rating on May 27, 2020, with a $24 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 17 ’23 when Forbes William P bought 25,000 shares for $1.09 per share. The transaction valued at 27,250 led to the insider holds 79,000 shares of the business.

Collard Craig A bought 150,000 shares of HRTX for $137,970 on Nov 16 ’23. The Chief Executive Officer now owns 186,496 shares after completing the transaction at $0.92 per share. On Nov 16 ’23, another insider, Duarte Ira, who serves as the EVP, Chief Financial Officer of the company, bought 85,000 shares for $0.89 each. As a result, the insider paid 75,599 and bolstered with 85,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HRTX now has a Market Capitalization of 432328160 and an Enterprise Value of 526152192. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.40. Its current Enterprise Value per Revenue stands at 4.141 whereas that against EBITDA is -5.839.

Stock Price History:

Over the past 52 weeks, HRTX has reached a high of $3.22, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is 5.79%, while the 200-Day Moving Average is calculated to be 57.30%.

Shares Statistics:

According to the various share statistics, HRTX traded on average about 2.26M shares per day over the past 3-months and 2558070 shares per day over the past 10 days. A total of 150.29M shares are outstanding, with a floating share count of 142.96M. Insiders hold about 5.10% of the company’s shares, while institutions hold 70.90% stake in the company. Shares short for HRTX as of 1713139200 were 25433045 with a Short Ratio of 11.25, compared to 1710460800 on 25426080. Therefore, it implies a Short% of Shares Outstanding of 25433045 and a Short% of Float of 19.479999.

Most Popular

[the_ad id="945"]